FrancineBleiMDMBA

Co-Director, Vascular Anomalies Program NYU Langone Health/Hassenfeld Children's Hospital

Dr. Blei is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Stern School of Business of NYUMBA, 2008 - 2010
New York Presbyterian Hospital (Columbia Campus)Fellowship, Pediatric Hematology/Oncology, 1985 - 1987
NYU Grossman School of MedicineResidency, Pediatrics, 1982 - 1985
Tel Aviv University SacklerClass of 1982
Duke UniversityBA

PubMed

190 citations
RASA1 Mutations and Associated Phenotypes in 68 Families with Capillary Malformation–Arteriovenous Malformation
Nicole Revencu, Laurence M. Boon, Antonella Mendola, Maria R. Cordisco, Josée Dubois
Human Mutation. 2013-12-01
160 citations
Germline Loss-of-Function Mutations in EPHB4 Cause a Second Form of Capillary Malformation-Arteriovenous Malformation (CM-AVM2) Deregulating RAS-MAPK Signaling
Mustapha Amyere, Nicole Revencu, Raphaël Helaers, Eleonore Pairet, Eulalia Baselga
Circulation. 2017-09-12
349 citations
Initiation and Use of Propranolol for Infantile Hemangioma: Report of a Consensus Conference
Beth A. Drolet, Peter C. Frommelt, Sarah L. Chamlin, Anita N. Haggstrom, Nancy M. Bauman
Pediatrics. 2013-01-01

Journal Articles

Clinical Practice Guideline for the Management of Infantile Hemangiomas
Daniel P Krowchuk, Francine Blei, Peter C Frommelt, Janice L Pelletier, Deborah Sandrock, AAP News

Clinical Practice Guideline for the Management of Infantile HemangiomasJanuary 2019

Vascular Anomilies, 2005-Research And ControversiesNational Heart, Lung, And Blood Institute2005
Vascular Anomalies, 2003 - Research: ControversiesNational Heart, Lung, And Blood Institute2003
Vascular Anomalies: Investigations Of Etiologic FactorsNational Heart, Lung, And Blood Institute2000–2003
Vascular Anomalies--Investigations Of Etiologic FactorsNational Heart, Lung, And Blood Institute1999
Therapy Of Angiomatous Disease With Interferon Alpha-2aNational Center For Research Resources1996–1997
Therapy Of Angiomatous Disease With Interferon Alpha-2aNational Center For Research Resources1995–1996